Recently, we and others have reported that the ETS family transcription factor Etv2 (also called Etsrp71/ER71) is
ndothelial dysfunction is a cardinal feature of several human cardiovascular diseases. 1 During embryogenesis, growth and survival of the vertebrate embryo rely critically on proper morphogenesis and homeostasis of the organs, tissues, and cell types that comprise the circulatory and cardiovascular systems. 2 Endothelial and blood progenitor cells of the circulatory system derive from a common ancestor known as the hemangioblast. 3, 4 Progenitor cell survival, specification, and differentiation require precisely orchestrated-interacting action of numerous transcription factors. However, details of the transcriptional network that governs endothelial cell (EC) function and homeostasis during embryogenesis are still being defined. Elegant work using gene disruption and mutation strategies has demonstrated that diverse transcription factors are involved in vascular development. 5 Among them, the importance of the E26 transforming-specific (ETS) family of transcription factors has been highlighted. 5 The ETS family of transcription factors is conserved in metazoans and first identified in avian erythroblastosis virus, E26. 6, 7 They are highly conserved in their DNA-binding ETS domain and govern a plethora of biological processes, including, but not limited to, development, cellular growth, differentiation, cell-cell contact, and viability. 5, 8 To date, 29 different Ets genes have been identified in mammals. Each binds to a core GGAA/T DNA-binding element, 6, 7 suggesting that aspects of their functions overlap. Global inactivation or mutation of numerous Ets genes either in mouse or in zebrafish indicates that despite high conservation of the DNA-binding motif and recognition of a similar cis-regulatory element, certain ETS factors play an essential role in vascular morphogenesis and homeostasis, which cannot be compensated by other family members. 5 essential for the genesis of hemato-endothelial progenitor cells in mice. [9] [10] [11] Mice lacking Etv2 die in utero around embryonic day 9.5 with complete loss of vasculature. 9, 11 Similarly, knockdown of the Etv2 ortholog Ets-related protein in zebrafish provokes a profound impairment of vasculogenesis. 12 Furthermore, recent studies demonstrate that loss of the Etv2/ Ets-related protein in mice and zebrafish redirects endothelial progenitor cells to a myogenic fate, 13, 14 highlighting a central role for this transcription factor in endothelial specification and vascular development in the early embryo. Intriguingly, endothelial expression of Etv2 in wild-type (WT) mice is undetectable at midgestation, 9-11 thus raising 2 major questions: (1) how are vascular morphogenesis and integrity maintained through the remainder of gestation? and (2) what controls the continued expression of known Etv2 target genes, such as Tie2 (also known as Tek), 9 in the absence of Etv2? Genome-wide sequence analyses identified Ets-binding sites (EBSs) in the promoter and enhancer regions of many endothelial-expressed genes, including ones encoding other ETS proteins. 5, 15 Therefore, we postulated that once expression of an Ets gene is activated by Etv2 early in the development, an Etv2-targeted Ets gene may function to maintain its own expression as well as that of additional endothelial genes involved in EC survival, vascular morphogenesis, and homeostasis. Recently published studies demonstrate that compared with WT embryos and embryonic stem cells (ESCs), transcript levels of several transcription factors involved in hematopoietic and vascular development during early embryogenesis are attenuated in Etv2 knockout embryos and ESCs. 11, 16, 17 However, the identity of a specific Etv2 target and its role in vascular morphogenesis in the absence of Etv2 remain elusive.
The primary purpose of this study was to identify a specific Etv2 target, which can activate a positive autoregulatory feedback mechanism that persists beyond midgestation (and in the absence of Etv2) to govern critical elements of embryonic vasculogenesis. We demonstrate that Friend leukemia integration 1 (Fli1) has such properties, being dependent on Etv2 to initiate embryonic expression early in the development and then acting to regulate its own expression, as well as that of additional Etv2 target endothelial genes involved in EC survival, vascular morphogenesis, and homeostasis, at and beyond midgestation.
Methods Lentivirus Production, Purification, and Infection
Hemagglutinin-tagged mouse Fli1 cDNA was subcloned into a lentiviral expression vector (Clontech) and cotransfected with pCD/NL-BH and pMD2-VSVG constructs into human embryonic kidney (HEK) 293T cells according to the manufacturer's instructions (Clontech). Lentivirus was harvested from the culture supernatant and concentrated using ultracentrifugation for 2 hours at 22 000 rpm (41 000g) using SW28 rotor. Expanded protocols for viral infection, gene expression, and histological and immunohistochemical analyses using isolated mouse embryos are provided in the Online Data Supplement.
Results

Excessive EC Death Leads to Hemorrhage in Fli1-
Null Embryos at Midgestation
We and others have reported that mice lacking Fli1 die between embryonic days 12.0 and 12.5 because of widespread hemorrhage at midgestation. 18, 19 However, the underlying cause of this perturbation is unknown. To gain insights into mechanisms underlying vascular leakage in Fli1-null embryos, we mated Fli1 heterozygous mice 19 and isolated WT and Fli1-null embryos from timed pregnant females at distinct developmental stages. Consistent with previously reported studies, 18, 19 Fli1-null embryos isolated at embryonic day 10.5 ( Figure 1A ) and embryonic day 11.5 ( Figure 1B ) manifested hemorrhage within the embryo proper as well as in the extraembryonic (eg, yolk sac) vasculature (data not shown) culminating ultimately in lethality by embryonic day 12.0 (Online Figure IA) . This was further supported by the absence of erythrocytes within the vasculature (eg, the dorsal aorta and cardinal vein) and hemorrhage in the canal of the neural tube of Fli1-null, but not WT, embryos ( Figure 1A ). In addition, Fli1-null embryos also revealed diminished endocardial cushion formation (Online Figure IB) , supporting a role of Fli1 in endocardial endothelium.
In contrast, Fli1-null embryos isolated at embryonic day 8.5 (data not shown) and embryonic day 9.5 (Online Figure  IIA) are indistinguishable from WT littermates in terms of overall morphology, growth, and cardiovascular structures. The presence of erythrocytes within the dorsal aorta of Fli1-null embryos and immunohistochemical analyses for the endothelial/endocardial marker α-endomucin 9 supported the notion that embryonic vascular structures were normal in early (between embryonic days 8.5 and 9.5) WT and Fli1-null littermates (Online Figure IIA and IIB). This conclusion was further supported by similar transcript levels of 2 endothelial genes in both genotypes at embryonic day 9.5 (Online Figure  IIC) . Collectively, these data support an essential role for Fli1 in vascular morphogenesis and homeostasis at midgestation.
Next, we analyzed whether vascular leakage in Fli1-null mice is associated with perturbation of endothelial proliferation and viability. Immunohistochemical analyses for Ki67 demonstrated normal cellular proliferation in Fli1-null and WT littermates at embryonic day 10.5 (Online Figure IB) , suggesting that disruption of vascular integrity was not because of lack of endothelial proliferation. Using terminal deoxynucleotidyl transferase dUTP nick-end labeling and immunohistochemical analyses for activated caspase-3 and endomucin, we tested for evidence of apoptotic cell death in WT and Fli1-null embryos. Compared with WT embryos, Fli1-null embryos isolated at midgestation manifested excessive EC death ( Figure 1A and 1B) . It is worth noting that elevated levels of cell death within the blood and cells of the neuropil were also evident in Fli1-null embryos (Figure 1 ; Online Figure IB ). Taken together, we conclude that Fli1 is essential for EC viability and homeostasis at and beyond midgestation.
Etv2 Is an Essential Upstream Regulator of the Fli1 Gene
Having identified an essential role for Fli1 in ECs at and beyond midgestation, we sought to determine molecular mechanisms governing embryonic expression of the Fli1 gene. Embryonic expression of Fli1 occurring after Etv2 expression 16 coupled with significant attenuation of Fli1 transcript levels in Etv2-null ESCs 16, 17 and ECs 13 together imply that Etv2 governs Fli1 expression in the early embryo. To test this concept, we purified RNA from embryonic day 8.0 WT and Etv2-null littermates 9 and analyzed transcript levels of numerous Ets genes. Quantitative reverse transcriptase polymerase chain reaction (PCR) analyses showed that compared with WT, transcript levels of Fli1 and a closely related Fli1 family member Erg 5 were significantly attenuated in Etv2-null embryos (Figure 2A ). In contrast, the transcript levels of several other Ets genes, including Ets1, Ets2, Elf1, Elf2, and Etv6, were unaffected ( Figure 2A ). Transcript levels of the Tie2 gene, an established downstream target of Etv2 in early embryo, 9 were also significantly decreased in mutant embryos (Figure 2A ), which suggests that attenuation of Fli1 expression in the Etv2-null embryos was specific to the absence of Etv2. Based on these data, we hypothesized that Fli1 is a downstream target of Etv2 in the early mouse embryo.
It has been demonstrated that synthesis of 2 major isoforms of the Fli1 protein initiates from 2 distinct translation initiation sites (ATG) present within exons 1 and 2, respectively ( Figure 2B ). 20 To confirm that Etv2-dependent Fli1 gene transcription initiates from exon 1, we used semiquantitative reverse transcriptase PCR techniques to analyze Fli1 transcripts using primers spanning the exon 1 untranslated region and exon 2 ( Figure 2B ). We noted that Fli1 transcripts detected in WT embryos were significantly attenuated in Etv2-null embryos ( Figure 2B ). These data suggest that marked reduction of Fli1 transcripts in the Etv2-null embryos was associated with Etv2-dependent regulation of Fli1 gene transcription from exon 1.
We, and others, have reported that endothelial expression of the Etv2 gene stops at midgestation (embryonic days 10.5-11.5). [9] [10] [11] This observation raised the possibility that expression of the Fli1 gene in whole embryo and in ECs will also be undetectable or decline at midgestation. Using semiquantitative and quantitative reverse transcriptase PCR, we analyzed Etv2 and Fli1 gene expression in whole embryo and in green fluorescence protein-positive ECs isolated from Tie2-green fluorescence protein mice at distinct developmental stages. Consistent with our previously published study, 9 the Etv2 gene was expressed in the early embryos (embryonic days 8.5-9.5; Online Figure IIIA ) and ECs ( Figure 2C ), but its expression was undetectable at midgestation. In contrast, Fli1 transcripts were detected at all developmental stages and increased with age in whole embryos (Online Figure IIIA) and ECs ( Figure 2C ). Taken together, we conclude that Etv2 is required for endothelial Fli1 expression in the early embryo, whereas Fli1 expression at and beyond midgestation becomes Etv2 independent. To complement our in vivo Etv2 loss-of-function data, we undertook in vitro approaches to validate Fli1 as a downstream target gene of Etv2. We fused a 0.7-kb Fli1 promoter region upstream of exon 1 harboring numerous conserved Ets-binding sites (EBSs) (Online Figure IIIB) 21,22 to a luciferase reporter cassette and conducted transcriptional analyses. Cotransfection of the reporter plasmid with increasing amounts of hemagglutinin-tagged Etv2 expression plasmid 9 in primary human aortic ECs (HAECs) resulted in significant activation of luciferase activity ( Figure 2D ). Because expression of numerous endothelial genes can be regulated by cooperative action of several ETS family transcription factors, including Etv2, [9] [10] [11] 15 we repeated transcriptional assays in non-ECs. Cotransfection of the reporter plasmid with Etv2 expression plasmid in C2C12 (Online Figure IIIC) or COS1 ( Figure 2E ) cells resulted in significant and dose-dependent activation of luciferase activity. However, cotransfection of To test for the presence of EBSs in the Fli1 promoter critical for Etv2 activity, we generated a series of deletion constructs of the 0.7-kb promoter fragment (Online Figure  IVA) . In transcriptional assays using each reporter plasmid in the presence or absence of Etv2, we identified 3 conserved EBSs, residing between 200-and 250-bp upstream of the ATG, that were essential and sufficient for Etv2-dependent activation of luciferase activity ( Figure 2F ; Online Figure  IVA) . Mutation of these EBSs disrupted Etv2-dependent activation of luciferase activity ( Figure 2G ; Online Figure  IIIB Figure IVC) . Collectively, these data suggest that Etv2 is an important upstream regulator of the Fli1 gene and that ectopic Etv2 expression will activate Fli1 expression in a cell autonomous manner.
Fli1 Promotes Its Own Expression in the Absence of Etv2
Having established Fli1 as an essential downstream target of Etv2 in early embryos, we set out to unveil molecular mechanisms underlying Etv2-independent transcriptional regulation of Fli1 expression at and beyond midgestation. Normal transcript levels of selected Ets genes in Etv2-null embryos ( Figure 2A ) along with the absence of vascular abnormalities at midgestation in mice lacking these factors 5 suggest that they are not required for Fli1 expression at midgestation. Moreover, significant attenuation of transcript levels of Etv2 target genes, Erg and Gata2, in Fli1-null embryos at embryonic day 10.5 (Online Figure VA) suggests that they are also not involved in Fli1 expression at midgestation. Based on these data, we hypothesized that Fli1 regulates its own promoter activity in the absence of Etv2.
To test this hypothesis, we analyzed the N-terminal transcript levels of Fli1 in Fli1-null embryos, which express little Fli1 protein that lacks the C-terminal activation domain encoded by the exon 9. 19 We detected Fli1 transcripts spanning the exon 1 untranslated region and exon 2 in embryonic day 9.5, but not in embryonic days 10.5 and 11.5, Fli1-null embryos ( Figure 3A) , whereas Fli1 transcripts at these developmental stages were readily detected in WT embryos (Online Figure IIIA) . These data suggest that Fli1 is dispensable for Fli1 expression in early embryos but required for sustained expression at midgestation. To complement this observation, we performed chromatin immunoprecipitation assays using WT embryos isolated at distinct developmental stages and confirmed increased Fli1 occupancy of its own promoter in embryos isolated at embryonic day 11.5 ( Figure 3B and 3C) . Surprisingly, such occupancy was not detected in embryos isolated at embryonic day 9.5 or in the Fli1 intronic region in embryos isolated at embryonic day 11.5 ( Figure 3B and 3C) . Collectively, these data lend strong support to our hypothesis that Fli1 occupancy of its own promoter region was associated with sustained endothelial Fli1 expression at midgestation in the absence of Etv2 ( Figure 2C ).
To complement these in vivo data, we performed transcriptional assays using an Fli1 reporter construct. In COS1 cells, we detected robust and dose-dependent activation of luciferase activity by Fli1 from an Fli1 reporter plasmid harboring WT ( Figure 3D ), but not mutated ( Figure 3E ), EBSs. Using chromatin immunoprecipitation quantitative PCR, Western blot, and reverse transcriptase PCR analyses using primers designed to amplify only endogenous Fli1 transcripts, we further demonstrated that Fli1 occupancy of its own promoter region in C2C12 cells can induce endogenous Fli1, but not Etv2, transcript levels (Online Figure VB-VD) . These data further support our hypothesis that Fli1 acts downstream of Etv2 and can activate its own promoter activity. Interestingly, the activation of Fli1 reporter activity by Etv2 or Fli1 was indistinguishable from that of other ETS factors, including Elf1 and Elf2 ( Figure 3E ). However, we found that unlike Etv2 and Fli1, ectopic expression of Elf1 and Elf2 in C2C12 cells did not induce endogenous Fli1 expression and that expression of Ets1 showed only a modest effect ( Figure 3F ). Together, these data suggest that the failure of Elf1/Elf2 to induce endogenous Fli1 gene expression was secondary to an inability to access the EBS sites in native chromatin but not because of an inability to recognize the EBSs in the Fli1 reporter plasmid. Based on our in vitro and in vivo data, we conclude that in the absence of Etv2 at midgestation, Fli1 binds to conserved EBSs within the Fli1 promoter to induce its own expression via positive autoregulation.
Fli1 Is Required for Endothelial Fli1 Expression for the Remainder of Gestation
To determine whether feed-forward autoregulation of Fli1 is essential for sustained Fli1 expression during the remainder of gestation, we undertook Fli1 loss-and gain-of-function strategies in adult primary HAECs. Consistent with our recent findings of Fli1 expression in adult mouse ECs, 23 we detected marked reduction of Fli1 transcript (Online Figure VE) and protein ( Figure 4A ) levels in HAECs using 2 independent Fli1-specific small interfering RNAs. We also noted that compared with COS1 cells, baseline Fli1 reporter activity was significantly higher in HAECs (data not shown), suggesting that endogenous Fli1 might activate its own reporter activity. To test this concept, we analyzed Fli1 reporter activity in HAECs and found that knockdown of Fli1 significantly attenuated Fli1 reporter activity ( Figure 4B ). Using chromatin immunoprecipitation quantitative PCR, we detected Fli1, but not Erg, occupancy of the Fli1 promoter region in HAECs ( Figure 4C ). Taken together, we conclude that Fli1 is required to maintain Fli1 expression in adult ECs.
To further test our model, we undertook Fli1 gain-offunction approaches finding that cotransfection of an Fli1 reporter construct and hemagglutinin-tagged Fli1 expression plasmids in HAECs resulted in significant and dose-dependent induction of luciferase activity ( Figure 4D ). Furthermore, lentivirus-mediated overexpression of mouse Fli1 in HAECs resulted in marked induction of endogenous Fli1 transcript levels ( Figure 4E ). Collectively, these data lend additional support to our hypothesis that Fli1 is essential for sustained Fli1 expression at and beyond midgestation.
Fli1 Is an Upstream Regulator of Selected Etv2-Regulated Endothelial Genes in Developing and Adult Endothelium
Finally, we set out to investigate whether Fli1 is essential for sustained expression of selected Etv2 target endothelial genes involved in EC viability and vascular homeostasis. For example, mice lacking Tie2, an endothelial receptor tyrosine kinase 24, 25 and vascular endothelial cadherin 5, 26, 27 manifest excessive EC death, abnormal vascular remodeling, hemorrhage, and embryonic lethality. Consistent with previously reported studies, 18, 23 transcript levels of Tie2, Cdh5, and Cd31, but not Vegf-A and Flk1/Vegfr2, genes were significantly attenuated in Fli1-null embryos at embryonic day 10.5 ( Figure 5A ). Furthermore, similar transcript levels of the myogenic transcription factor myogenin in both genotypes at embryonic day 10.5 suggest that attenuation of transcript levels of endothelial genes, including Tie2, was specific to the loss of Fli1. Immunohistochemical analyses for Tie2 and Fli1 also supported the notion that significant attenuation of Tie2 protein levels in vascular ECs of Fli1-null littermates was associated with EC-specific loss of Fli1 (Online Figure VIA) . Given that Tie2 transcripts in Fli1-null embryos declined to a similar extent in Etv2-null embryos (Figure 2A) , we reasoned that the regulation of endothelial genes abundance in midgestational endothelium occurred at the level of gene transcription. It has been reported that an upstream promoter fragment (UPF) and a distal first intronic enhancer fragment are essential for sustained endothelial Tie2 expression at mid-and late gestation. 28 Moreover, both the UPF and the intronic enhancer fragment have been reported to harbor several conserved EBSs. 9 Therefore, we examined whether immunoprecipitation of Fli1-DNA complexes from embryos ( Figure 3B ) harvested regulatory elements of Tie2 and a known Fli1 downstream target Cdh5. 23 Consistent with our previous report, 23 we detected Fli1 occupancy of the Cdh5 promoter in vivo ( Figure 5B ). In fact, we also noted Fli1 occupancy of conserved EBSs within the UPF ( Figure 5B ) and intronic enhancer fragment (Online Figure VIB) of the Tie2 gene in embryos isolated at embryonic day 11.5, but not at embryonic day 9.5. These data suggest that Fli1 binds to the conserved EBSs within the promoter of selected Etv2 target endothelial genes, including Tie2, to govern their expression at and beyond midgestation.
To complement our in vivo data, we undertook Fli1 loss-and gain-of-function strategies and analyzed transcript levels of Tie2 and Cdh5 in vitro. We found that small interfering RNAmediated knockdown of Fli1 in HAECs resulted in marked reduction of transcripts levels of Tie2 and Cdh5 ( Figure 5C ). Furthermore, cotransfection of the Tie2 reporter with increasing amounts of Fli1 expression plasmid in COS1 cells revealed marked and dose-dependent induction of luciferase activity, whereas mutation of the EBSs in a 2.1-kb UPF of the Tie2 gene 9 significantly attenuated the induction of reporter activity ( Figure 5D ). Importantly, ectopic Fli1 expression in C2C12 cells (Online Figure VIC) and HAECs ( Figure 5E ) resulted in significant induction of endogenous Tie2 expression. Thus, we conclude that in the absence of Etv2 at midgestation, Fli1 governs EC survival and vascular integrity by regulating expression of selected Etv2 target transcription (Online Figure VA) and signaling (eg, Tie2) factors at and beyond midgestation.
Discussion
The overall goal of this study was to decipher the Etv2-mediated transcriptional network that integrates vascular morphogenesis from early to late gestation in the developing mouse embryo. Our study reports 3 important findings. First, using a combination of molecular and Etv2 loss-and gain-offunction experiments, we have identified Fli1 as a downstream target of Etv2 in the early embryo and defined the underlying regulatory mechanisms. Second, we have uncovered a previously unrecognized positive autoregulatory mechanism controlling Fli1 gene expression at and beyond midgestation, thereby providing insight into mechanisms governing vascular morphogenesis and homeostasis in the absence of Etv2. We demonstrate that when Etv2 expression is extinguished, Fli1 acts to regulate its own expression, as well as that of selected other Etv2 target genes, at and beyond midgestation. In doing so, it governs EC viability and vascular integrity, which accounts for the vascular leakage and ultimate embryonic lethality reported in Fli1 mutant mice. 18, 19 Third, we have identified Fli1 as an upstream regulator of Tie2 and demonstrated that Fli1 binds to the conserved EBS within the UPF and intronic enhancer fragment of the Tie2 gene to regulate endothelial Tie2 expression at and beyond midgestation. Collectively, our findings identify Etv2 and Fli1 as a classic example of a feedforward autoregulatory feedback loop that initiates and maintains vascular morphogenesis, homeostasis, and subsequent fetal growth and survival during development.
Since the discovery of Etv2 as an essential regulator of endothelial fate of progenitor cells and its temporal and spatial expression pattern in the EC of early mouse embryo, [9] [10] [11] the general consensus has been that Etv2 activates a downstream transcriptional network in early embryo, which in turn regulates EC homeostasis and vascular morphogenesis in the absence of Etv2. Indeed, compared with WT ESCs 16,17 and 16 highlighting the physiological significance of cis-regulatory motifs within the Fli1 promoter region for transcriptional regulation of Fli1 expression by Etv2.
Although all ETS factors recognize a similar cis-regulatory element, 6 ,7 attenuation of Fli1 expression in Etv2-null mice was not complemented by several other ETS factors, which are known to be expressed in ECs. 21, 22 However, all of them, including Elf1 and Elf2, induced Fli1 reporter activity in vitro. These data suggest that the binding specificity of ETS factors to a cis-regulatory element is uniquely regulated in native chromatin, which is often indistinguishable in naked DNA. It is also plausible that the transcriptional regulation of Fli1 and Tie2 genes by other ETS factors in endothelial and nonECs is context dependent or dependent on their cooperative action with other family members. Indeed, cooperative actions among numerous ETS factors, including Etv2, Fli1, and Erg, and other transcription factors are known to play essential roles in endothelial gene expression during development. 10, 31 Consistent with these studies, a cooperative action between Fli1 and Erg is required for hematopoiesis in mice, 32 and mice lacking Fli1 and endothelial isoforms of Erg (isoforms 5-7) 33 manifest vascular and cardiac malformations at midgestation. Therefore, it is conceivable that a cooperative action between Fli1 and other ETS factors governs endothelial gene expression and vascular morphogenesis in the absence of Etv2.
Autoregulation of gene expression is a common theme among transcription factors that govern expression of a large number of genes during embryogenesis. 34 Although autoregulatory mechanisms can be positive or negative, the significance of autoregulation relates to maintenance of cell fate and cellular homeostasis. Positive autoregulation has been described for numerous developmental transcription factors, including, but not limited to, paired box protein 6 (Pax6), 35 homeobox (Hox) proteins, and several myogenic factors, MyoD and myocyte enhancer factor 2 (Mef2), 34, 36, 37 which are essential for cardiac and skeletal myogenesis. For example, the basic helix-loop-helix transcription factor Twist, which governs mesodermal specification and myogenesis, 36 and Mef2 proteins are coexpressed during early phases of mesodermal development. However, Twist expression is extinguished before muscle cell differentiation, whereas Mef2 expression persists throughout mesodermal development and subsequent muscle differentiation. 34 Of interest is that positive autoregulatory mechanisms related to Twist and Mef2 in skeletal myogenesis parallel those reported here for Etv2 and Fli1 in vascular morphogenesis.
Our model suggests that in the early embryo, Etv2 activates a transcriptional network 16, 17 involving Fli1 and Tie2 9 to govern the hemato-endothelial fate of progenitor cells and subsequent fetal growth and survival (Figure 6 ). At midgestation, when Etv2 expression turns off, Fli1 autoregulates its own expression as well as that of selected Etv2 target genes (such as Erg, Cdh5, and Tie2) for the remainder of gestation to govern EC survival and vascular integrity ( Figure 6 ). Consistent with our model, endothelial expression of a lacZ reporter driven by the native Fli1 promoter is significantly diminished at midgestation and undetectable at embryonic day 14.5 in Fli1-null embryos, whereas reporter expression in ECs persists in Fli1-heterozygous embryos during these developmental stages. 18, 19 In contrast, endothelial expression of a lacZ reporter driven by the native Erg promoter is not reduced in Erg-null embryo at midgestation, 33 suggesting that Fli1, but not Erg, is required to govern its own promoter activity at midgestation. Although embryonic lethality of Etv2-null mice is not associated with excessive EC death, 9 our data along with previously published studies [24] [25] [26] [27] support a model in which attenuation of endothelial Tie2 and Cdh5 expression is associated with excessive EC death in Fli1-null embryos. However, we cannot rule out the possibility that additional factors might be involved in this process. Previously, we demonstrated that Etv2 governs Tie2 expression in early embryonic ECs, 9 yet the molecular mechanisms underlying transcriptional regulation of Tie2 expression at and beyond midgestation were unknown. Our study is the first to report that Fli1 is an important regulator of endothelial Tie2 expression at and beyond midgestation.
In conclusion, we have uncovered a unique and previously unrecognized positive autoregulatory transcriptional circuit whereby coordinated transcriptional activity of Etv2 and Fli1 regulates vascular morphogenesis and homeostasis at distinct stages of embryogenesis. Given the essential role of Fli1 in cardiovascular morphogenesis and vascular inflammation, 6, 7 it is conceivable that Fli1 may be intimately involved in vascular and cardiovascular diseases. Moreover, Fli1 is associated with thymus development and cancer pathogenesis. [38] [39] [40] 
